Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21251912rdf:typepubmed:Citationlld:pubmed
pubmed-article:21251912lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C0158683lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C0537506lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C1427303lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C1704666lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C1517892lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C1999230lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C1705492lld:lifeskim
pubmed-article:21251912lifeskim:mentionsumls-concept:C0208973lld:lifeskim
pubmed-article:21251912pubmed:issue4lld:pubmed
pubmed-article:21251912pubmed:dateCreated2011-2-15lld:pubmed
pubmed-article:21251912pubmed:abstractTextThe formation of multiple cysts in one or several organs is a characteristic of several human inherited diseases. Recent research suggests that problems in planar cell polarity may be the common denominator in polycystic diseases. Mutations in at least two genes are linked to autosomal dominant polycystic liver disease (PCLD), PRKCSH and SEC63. A recent study linked PRKCSH to the signaling- and cytoskeletal adaptor-component ?-catenin. In a yeast two hybrid screen we identified the cytosolic protein nucleoredoxin (NRX) as an interaction partner of human Sec63. Since NRX is involved in the Wnt signaling pathways, we characterized this interaction. Thus, Sec63 is linked to the Wnt signaling pathways and this interaction may be the reason why mutations in SEC63 can lead to PCLD.lld:pubmed
pubmed-article:21251912pubmed:languageenglld:pubmed
pubmed-article:21251912pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:citationSubsetIMlld:pubmed
pubmed-article:21251912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21251912pubmed:statusMEDLINElld:pubmed
pubmed-article:21251912pubmed:monthFeblld:pubmed
pubmed-article:21251912pubmed:issn1873-3468lld:pubmed
pubmed-article:21251912pubmed:authorpubmed-author:MikiHiroakiHlld:pubmed
pubmed-article:21251912pubmed:authorpubmed-author:ZimmermannRic...lld:pubmed
pubmed-article:21251912pubmed:authorpubmed-author:FunatoYosukeYlld:pubmed
pubmed-article:21251912pubmed:authorpubmed-author:MüllerLindaLlld:pubmed
pubmed-article:21251912pubmed:copyrightInfoCopyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:21251912pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21251912pubmed:day18lld:pubmed
pubmed-article:21251912pubmed:volume585lld:pubmed
pubmed-article:21251912pubmed:ownerNLMlld:pubmed
pubmed-article:21251912pubmed:authorsCompleteYlld:pubmed
pubmed-article:21251912pubmed:pagination596-600lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:meshHeadingpubmed-meshheading:21251912...lld:pubmed
pubmed-article:21251912pubmed:year2011lld:pubmed
pubmed-article:21251912pubmed:articleTitleAn interaction between human Sec63 and nucleoredoxin may provide the missing link between the SEC63 gene and polycystic liver disease.lld:pubmed
pubmed-article:21251912pubmed:affiliationMedical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany.lld:pubmed
pubmed-article:21251912pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21251912pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:11231entrezgene:pubmedpubmed-article:21251912lld:entrezgene
entrez-gene:64359entrezgene:pubmedpubmed-article:21251912lld:entrezgene
entrez-gene:18230entrezgene:pubmedpubmed-article:21251912lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21251912lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21251912lld:entrezgene